How many insider trades does FilingIQ track for MAIA?

FilingIQ tracks 153 Form 4 insider transactions for MAIA (MAIA Biotechnology, Inc.), covering filings from Aug 2, 2022 onwards. 7 of those are dated within the last 90 days.

Are MAIA insiders net buyers or net sellers?

Across the full Form 4 history for MAIA, 148 transactions (97%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MAIA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is MAIA in?

MAIA Biotechnology, Inc. (MAIA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $79.04M.

MAIA insider trading

NYSE American Healthcare

MAIA Biotechnology, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

153

Last 90 days

Buys / sells

97% / 0%

Market cap

$79.04M

About MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Company website: maiabiotech.com

MAIA insider activity at a glance

FilingIQ tracks 153 insider transactions for MAIA in filings since Aug 2, 2022. The most recent transaction is dated Sep 14, 2026.

Across the full history, 148 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MAIA insider trades is 51.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MAIA trades on FilingIQ Raw filings on SEC EDGAR

Latest MAIA Form 4 filings

Theagene Jean-Manasse

Vitoc Vlad Chief Executive Officer

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for MAIA?: FilingIQ tracks 153 Form 4 insider transactions for MAIA (MAIA Biotechnology, Inc.), covering filings from Aug 2, 2022 onwards. 7 of those are dated within the last 90 days.
Are MAIA insiders net buyers or net sellers?: Across the full Form 4 history for MAIA, 148 transactions (97%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MAIA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is MAIA in?: MAIA Biotechnology, Inc. (MAIA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $79.04M.

Methodology & sources

Every MAIA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.